VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-01298
Package ID: USCOURTS-cofc-1_18-vv-01298
Petitioner: Franklin Gallo
Filed: 2020-01-28
Decided: 2020-04-22
Vaccine: Tdap
Vaccination date: 2017-09-05
Condition: shoulder injury related to vaccine administration (SIRVA)
Outcome: compensated
Award amount USD: 97500

AI-assisted case summary:
Franklin Gallo, an adult, received a Tdap vaccine on September 5, 2017. He alleged that he suffered a shoulder injury related to vaccine administration (SIRVA) as a result of this vaccination. The case was filed on January 28, 2020. A ruling on entitlement was issued on January 28, 2020, finding that there was preponderant evidence to establish that the Tdap vaccine was administered to Petitioner in the left deltoid. Respondent conceded that Petitioner suffered a SIRVA related to his vaccination and that he suffered residual effects for more than six months. Respondent also agreed that Petitioner satisfied all legal prerequisites for compensation. Based on this concession and the evidence, the court found Petitioner entitled to compensation. Subsequently, on April 22, 2020, a decision awarding damages was issued. Respondent filed a proffer on award of compensation, indicating that Petitioner should be awarded $97,500.00, which Petitioner agreed to. This amount represents compensation for all damages available under the Act, including pain and suffering, with projected pain and suffering reduced to net present value. The court awarded Petitioner a lump sum payment of $97,500.00.

Theory of causation field:
Table

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-01298-0
Date issued/filed: 2020-01-07
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 12/05/2019) regarding 26 Findings of Fact & Conclusions of Law Signed by Chief Special Master Brian H. Corcoran. (ypb) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01298-UNJ Document 28 Filed 01/07/20 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 18-1298V
UNPUBLISHED
FRANKLIN GALLO, Chief Special Master Corcoran
Petitioner, Filed: December 5, 2019
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Findings of Fact; Site of Vaccination
HUMAN SERVICES, Tetanus Diphtheria acellular
Pertussis (Tdap) Vaccine; Shoulder
Respondent. Injury Related to Vaccine
Administration (SIRVA)
Leah VaSahnja Durant, Law Offices of Leah V. Durant, PLLC, Washington, DC, for
petitioner.
Julia Marter Collison, U.S. Department of Justice, Washington, DC, for respondent.
FINDINGS OF FACT1
On August 27, 2018, Franklin Gallo filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the
“Vaccine Act”). Petitioner alleges that he suffered a left shoulder injury related to vaccine
administration (“SIRVA”) as a result of a tetanus, diphtheria, acellular pertussis (“Tdap”)
vaccine administered on September 5, 2017. Petition at 1. The case was assigned to
the Special Processing Unit of the Office of Special Masters.
1 Because this unpublished decision contains a reasoned explanation for the action in this case, I am
required to post it on the United States Court of Federal Claims' website in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic
Government Services). This means the decision will be available to anyone with access to the
internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact
medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy.
If, upon review, I agree that the identified material fits within this definition, I will redact such material from
public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2012).

Case 1:18-vv-01298-UNJ Document 28 Filed 01/07/20 Page 2 of 7
For the reasons discussed below, I find that the Tdap vaccine alleged as causal
was administered in Petitioner’s left deltoid on September 5, 2017.
I. Relevant Procedural History
After filing his petition, Petitioner filed medical records, an affidavit, and a
Statement of Completion. ECF Nos. 7, 12-14. At the initial status conference, it was
noted that Petitioner’s affidavit references communications from Petitioner to the
Veterans Administration regarding his previous attempts to correct his September 5, 2017
vaccination record. ECF No. 15. Following the initial status conference, Petitioner was
ordered to file any associated records in connection with these communications. Id.
Additionally, Respondent was ordered to file a status report indicating how he intends to
proceed in this case. Id. On March 21, 2019, Petitioner filed records from the Veterans
Administration regarding his attempts to correct his vaccination record. ECF No. 16.
On June 13, 2019, Respondent filed a status report and Motion to Dismiss (“Res.
Motion”). ECF Nos. 19-20. Respondent asserted that Petitioner’s claim concerns a
vaccine not covered by the Vaccine Act. Res. Motion at 1. Specifically, Respondent
observed that Petitioner alleged that he suffered a SIRVA after receiving a Tdap
vaccination in his left shoulder on September 5, 2017. Id. However, Respondent noted
that Petitioner’s vaccination record documents that Petitioner was administered a Tdap
vaccine in his right deltoid, and a non-covered Pneumovax vaccine in his left deltoid. Id.
at 1-2. Additionally, Respondent cited a letter addressed to Petitioner from the Veterans
Administration noting that Petitioner’s vaccination record is accurate in its current form.
Id. at 2. Based on this evidence, Respondent argued that Petitioner’s claim must be
dismissed due to lack of jurisdiction or for failure to state a claim on which relief can be
granted. Id. at 2-3.
Petitioner filed a Response to Respondent’s Motion to Dismiss (“Pet. Response”)
on June 27, 2019, addressing Respondent’s arguments and asserting that Petitioner has
provided sufficient evidence to establish that the Tdap vaccine was administered in his
left deltoid. ECF No. 22. Petitioner cited numerous medical records in support of his
position and contended that there is at least a genuine issue of material fact regarding
the site of Petitioner’s Tdap vaccination. Pet. Response at 2-4. Respondent did not file
a reply.
On July 31, 2019, an order was issued denying Respondent’s Motion to Dismiss
because it was found that there is a genuine factual dispute as to the site of Petitioner’s
September 5, 2017 Tdap vaccination. ECF No. 23. The parties were therefore ordered
to file any relevant evidence they wished to have considered regarding the site of
Petitioner’s vaccination. Id. The parties were informed that a fact ruling would
subsequently be issued regarding the site of Petitioner’s vaccination. Id.
On August 28, 2019, Respondent filed a status report (“Res. Status Report”) in
which he reiterated his previous position that Petitioner failed to establish that he received
2

Case 1:18-vv-01298-UNJ Document 28 Filed 01/07/20 Page 3 of 7
a Tdap vaccine in his left arm on September 5, 2017. Res. Status Report at 1. Initially,
Respondent asserted that Petitioner had not provided evidence that he has the necessary
qualifications—e.g., medical background or training—to distinguish between the Tdap
and Pneumovax vaccines, which are both administered intramuscularly. Id. at 1-2.
Furthermore, Respondent noted that Petitioner’s post-vaccination statements regarding
the situs of his Tdap vaccination are based on his recollection alone. Id. at 2. Because
these later references are “not contemporaneous documentation by vaccine
administrators,” Respondent argued that they “deserve little weight with regard to
establishing the site of vaccination.” Id. Finally, Respondent observed that this case
involves a vaccination record that is contrary to Petitioner’s claims, plus a subsequent
letter from the Veterans Administration noting that Petitioner’s vaccination record is
accurate in its current form. Id. at 2-3. Respondent argued that Petitioner has not
established that his own recollection is more reliable than the aforementioned records
regarding the site of administration. Id.
On August 30, 2019, Petitioner filed additional medical records and affidavits from
four acquaintances. ECF No. 25. This matter is now ripe for adjudication.
II. Issue
At issue is whether Petitioner received the Tdap vaccination alleged as causal in
the injured left arm.
III. Authority
Pursuant to Vaccine Act § 13(a)(1)(A), a petitioner must prove, by a
preponderance of the evidence, the matters required in the petition by Vaccine Act
§ 11(c)(1). A special master must consider, but is not bound by, any diagnosis,
conclusion, judgment, test result, report, or summary concerning the nature, causation,
and aggravation of petitioner’s injury or illness that is contained in a medical record.
§ 13(b)(1). “Medical records, in general, warrant consideration as trustworthy evidence.
The records contain information supplied to or by health professionals to facilitate
diagnosis and treatment of medical conditions. With proper treatment hanging in the
balance, accuracy has an extra premium. These records are also generally
contemporaneous to the medical events.” Curcuras v. Sec’y of Health & Human Servs.,
993 F.2d 1525, 1528 (Fed. Cir. 1993).
Accordingly, where medical records are clear, consistent, and complete, they
should be afforded substantial weight. Lowrie v. Sec’y of Health & Human Servs., No.
03-1585V, 2005 WL 6117475, at *20 (Fed. Cl. Spec. Mstr. Dec. 12, 2005). However, this
rule does not always apply. In Lowrie, the special master wrote that “written records
which are, themselves, inconsistent, should be accorded less deference than those which
are internally consistent.” Lowrie, at *19.
3

Case 1:18-vv-01298-UNJ Document 28 Filed 01/07/20 Page 4 of 7
The United States Court of Federal Claims has recognized that “medical records
may be incomplete or inaccurate.” Camery v. Sec’y of Health & Human Servs., 42 Fed.
Cl. 381, 391 (1998). The Court later outlined four possible explanations for
inconsistencies between contemporaneously created medical records and later
testimony: (1) a person’s failure to recount to the medical professional everything that
happened during the relevant time period; (2) the medical professional’s failure to
document everything reported to her or him; (3) a person’s faulty recollection of the events
when presenting testimony; or (4) a person’s purposeful recounting of symptoms that did
not exist. La Londe v. Sec’y of Health & Human Servs., 110 Fed. Cl. 184, 203-04 (2013),
aff’d, 746 F.3d 1335 (Fed. Cir. 2014).
The Court has also said that medical records may be outweighed by testimony that
is given later in time that is “consistent, clear, cogent, and compelling.” Camery, 42 Fed.
Cl. at 391 (citing Blutstein v. Sec’y of Health & Human Servs., No. 90-2808, 1998 WL
408611, at *5 (Fed. Cl. Spec. Mstr. June 30, 1998)). The credibility of the individual
offering such testimony must also be determined. Andreu v. Sec’y of Health & Human
Servs., 569 F.3d 1367, 1379 (Fed. Cir. 2009); Bradley v. Sec’y of Health & Human Servs.,
991 F.2d 1570, 1575 (Fed. Cir. 1993).
The special master is obligated to fully consider and compare the medical records,
testimony, and all other “relevant and reliable evidence contained in the record.” La
Londe, 110 Fed. Cl. at 204 (citing § 12(d)(3); Vaccine Rule 8); see also Burns v. Sec’y of
Health & Human Servs., 3 F.3d 415, 417 (Fed. Cir. 1993) (holding that it is within the
special master’s discretion to determine whether to afford greater weight to medical
records or to other evidence, such as oral testimony surrounding the events in question
that was given at a later date, provided that such determination is rational).
IV. Finding of Fact
For the reasons discussed below, I find that the Tdap vaccine alleged as causal
was administered in Petitioner’s left deltoid on September 5, 2017, as Petitioner alleges.
I make this finding after a complete review of the record to include all medical records,
affidavits, and additional evidence filed. Specifically, I base the finding on the following
evidence:
• On September 5, 2017, Petitioner presented to the Miami Veterans Affairs
Medical Center (“VA Medical Center”) for a health maintenance
appointment, medication review, and annual physical. Petitioner’s Exhibit
(“Pet. Ex.”) 1 at 1. The associated medical record does document that
Petitioner “requested and received” a Tdap vaccination intramuscularly in
the right deltoid. Id. at 4. The medical record additionally reflects that
Petitioner “received” a Pneumovax vaccination intramuscularly in the left
deltoid.3 Id.
3 Petitioner sent an amendment request dated October 18, 2018 to the VA Medical Center to correct his
September 5, 2017 medical record to reflect that the Tdap vaccine was administered in his left deltoid and
4

Case 1:18-vv-01298-UNJ Document 28 Filed 01/07/20 Page 5 of 7
• One day later, on September 6, 2017, Petitioner called the VA Medical
Center to report pain at the “Tetanus shot site,” which he described as being
on his left arm. Pet. Ex. 2 at 52.
• On October 5, 2017, Petitioner presented to Holy Cross Medical Group with
complaints of left shoulder pain. Pet. Ex. 3 at 7. Petitioner stated that he
had recently been administered a tetanus vaccine and had experienced
pain since that time. Id.
• On October 24, 2017, Petitioner returned to the VA Medical Center.
Petitioner reported persistent left deltoid discomfort that started more than
one month prior following a Tdap vaccination. Pet. Ex. 2 at 46.
• On February 15, 2018, Petitioner presented to Ali A. Harake MDPA Practice
complaining of a five-month history of pain following the administration of a
tetanus vaccination in his left deltoid. Pet. Ex. 5 at 3.
• On March 15, 2018, Petitioner presented to Cleveland Clinic for treatment
of left shoulder pain. Pet. Ex. 6 at 64. Petitioner reported that he had
received a tetanus vaccination in September and soon thereafter developed
shoulder pain. Id.
• On August 28, 2018, Petitioner returned to Holy Cross Medical Group. Pet.
Ex. 3 at 21. Petitioner reported that he continued to have left shoulder pain
following a tetanus injection. Id.
• On December 6, 2018, Petitioner returned to Holy Cross Medical Group.
Pet. Ex. 8 at 1. Petitioner was noted to have a “history of worsening left
shoulder pain, starting after he received a tetanus shot in the left shoulder
over 1 year ago.” Id.
• On March 6, 2019, Petitioner filed a detailed affidavit providing additional
information regarding the September 5, 2017 medical appointment and his
subsequent treatment. Pet. Ex. 9. At the medical appointment, Petitioner
stated that he recalled “being alerted that the tetanus shot was about to be
administered in the left arm (being right handed).” Id. at ¶ 2. Petitioner
averred that he had suffered an adverse reaction to a tetanus-diphtheria
vaccination as a child, which led to significant medical complications. Id.
Petitioner stated that this childhood experience was “burned in [his]
memory.” Id. Accordingly, Petitioner asserted that he knew the arm in
which the Tdap vaccine was being administered during the September 5,
2017 medical appointment. Id.
that the Pneumovax vaccine was administered in his right deltoid. Pet. Ex. 10 at 1. In a reply
correspondence dated November 2, 2018, the Veterans Administration denied Petitioner’s request, noting
that Petitioner’s vaccination record is accurate in its current form. Id. at 4.
5

Case 1:18-vv-01298-UNJ Document 28 Filed 01/07/20 Page 6 of 7
• On August 30, 2019, Petitioner filed an affidavit from Arlan R. Best, an
acquaintance. Pet. Ex. 13. Mr. Best averred that Petitioner called him on
the evening of September 5, 2017 to complain that “he was experiencing
excruciating pain in his left arm where he had received a tetanus shot.” Id.
at ¶ 2. Petitioner also filed affidavits from three other acquaintances on
August 30, 2019, who similarly recalled that Petitioner attributed his left arm
symptoms to a tetanus injection in the days and weeks following his
September 5, 2017 vaccination. Pet. Exs. 12, 14-15.
In making the above finding regarding situs, I note that special masters have found
that vaccine administration occurred, or was incorrectly recorded, even in the absence of
direct documentation, based upon other medical records and/or witness testimony. More
broadly, witness testimony can be used to overcome the presumption of accuracy
afforded to contemporaneous medical records, if the testimony is “consistent, clear,
cogent, and compelling.” Camery, 42 Fed. Cl. at 391 (citing Blutstein v. Sec’y of Health
& Human Servs., No. 90-2808, 1998 WL 408611, at *5 (Fed. Cl. Spec. Mstr. June 30,
1998)).
Based upon my review of the record, I find that Petitioner has established by
preponderant evidence that he received the Tdap vaccine in his left arm. There is no
doubt that the primary evidence of vaccination documents Mr. Gallo’s right arm as the
situs of the Tdap vaccination. In many cases, such a document would resolve the dispute.
But I find that this entry specifying administration is rebutted by Petitioner’s
contemporaneous medical records, as well as his own recollection of the actual situs,
which together are sufficiently “clear, cogent, and compelling” to overcome the available
vaccination record.
In particular, Petitioner has provided a reasonable explanation for why he would
have recalled the arm in which the Tdap vaccine was administered. As described above,
Petitioner had suffered an adverse reaction to a tetanus-diphtheria vaccination as a child,
which led to significant medical complications.
Petitioner requested that the Tdap vaccine be administered in his left arm because
it is his nondominant arm. Pet. Ex. 9 at ¶ 2. Moreover, Petitioner stated in his affidavit
that he was informed, at the time of the vaccination, that the Tdap vaccine was about to
be administered in his left arm. Id. Accordingly, Petitioner asserted that he was cognizant
of the arm in which the Tdap vaccine was being administered during the September 5,
2017 medical appointment. Id.
I note that the vaccination record contains differing entries regarding the
administration of the Tdap and Pneumovax vaccines. Under the Tdap vaccine, Petitioner
was noted to have “requested and received [the vaccine] intramuscular[ly] in the right
deltoid.” Pet. Ex. 1 at 4 (emphasis added). Under the Pneumovax vaccine, however,
Petitioner was noted only to have “received [the vaccine] [intramuscularly] today in Left
Deltoid.” Id. (emphasis added).
I find the use of the phrase "requested and received" in describing one vaccine
(the Tdap), but not the other (Pneumovax) significant under the circumstances. Petitioner
has persuasively established he had a reasonable concern in specifying the arm for
6

Case 1:18-vv-01298-UNJ Document 28 Filed 01/07/20 Page 7 of 7
administration of the Tdap vaccine. The inclusion of both “requested” and “received”
under the Tdap vaccine suggests that Petitioner requested the arm in which the Tdap (but
not Pneumovax) vaccine would be administered. Given that Petitioner is right-handed
and has alleged a prior adverse reaction to a tetanus vaccine, I find the evidence supports
the conclusion that Petitioner requested that the Tdap vaccine be administered in his left
nondominant arm, but that the request and subsequent administration were incorrectly
recorded in his medical records.
Respondent has argued that Petitioner has not provided evidence that he has
qualifications—e.g., medical background or training—to distinguish between the Tdap
and Pneumovax vaccines, which are both administered intramuscularly. Res. Status
Report. at 1-2. I find, however, that a lack of additional qualifications is not dispositive in
this case. Indeed, as indicated above, Petitioner stated in his affidavit that he was
informed, at the time of the vaccination, that the Tdap vaccine was about to be
administered in his left arm. Pet. Ex. 9 at ¶ 2. Moreover, Petitioner’s contemporaneous
medical records—including from the day following the vaccination—specifically tie
Petitioner’s left shoulder symptoms to the Tdap vaccination and are thus corroborative of
his allegations.
The facts of this case present a close call on the issue of situs. Based upon my
review of the entire record, however, I find there is preponderant evidence to establish
that the Tdap vaccine alleged as causal in this case was administered to Petitioner in the
left deltoid on September 5, 2017.
V. Scheduling Order
Respondent shall file a status report, by no later than Tuesday, January 21, 2020,
indicating whether he is interested in exploring an informal resolution of Petitioner’s claim.
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
7

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_18-vv-01298-1
Date issued/filed: 2020-03-04
Pages: 2
Docket text: PUBLIC ORDER/RULING (Originally filed: 01/28/2020) regarding 30 Ruling on Entitlement Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01298-UNJ Document 33 Filed 03/04/20 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 18-1298V
UNPUBLISHED
FRANKLIN GALLO, Chief Special Master Corcoran
Petitioner, Filed: January 28, 2020
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Ruling on Entitlement; Concession;
HUMAN SERVICES, Table Injury; Tetanus Diphtheria
acellular Pertussis (Tdap) Vaccine;
Respondent. Shoulder Injury Related to Vaccine
Administration (SIRVA)
Leah VaSahnja Durant, Law Offices of Leah V. Durant, PLLC, Washington, DC, for
petitioner.
Julia Marter Collison, U.S. Department of Justice, Washington, DC, for respondent.
RULING ON ENTITLEMENT1
On August 27, 2018, Franklin Gallo filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the
“Vaccine Act”). Petitioner alleges that he suffered a shoulder injury related to vaccine
administration (“SIRVA”) as a result of a tetanus, diphtheria, acellular pertussis (“Tdap”)
vaccine administered on September 5, 2017. Petition at 1. The case was assigned to
the Special Processing Unit of the Office of Special Masters.
1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am
required to post it on the United States Court of Federal Claims' website in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). This means the ruling will be available to anyone with access to
the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to
redact medical or other information, the disclosure of which would constitute an unwarranted invasion of
privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such
material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).

Case 1:18-vv-01298-UNJ Document 33 Filed 03/04/20 Page 2 of 2
On December 5, 2019, a Fact Ruling was issued finding that there is
preponderant evidence to establish that the Tdap vaccine alleged as causal in this case
was administered to Petitioner in the left deltoid on September 5, 2017. Fact Ruling at
2, 7 (ECF No. 26).
On January 21, 2020, Respondent filed a Rule 4(c) Report indicating that,
although he reserves his right to a potential appeal of the factual ruling, he recognizes
the factual finding regarding the situs of Petitioner’s Tdap vaccination is “the law of the
case . . . [and] advises that he will not defend the case on other grounds during further
proceedings before the Office of Special Masters.” Res. Report at 2 (ECF No. 29).3
Respondent indicates that “[i]n light of the Chief Special Master’s fact ruling, and
medical record evidence submitted in this case, DICP has concluded that petitioner
suffered a SIRVA related to his September 5, 2017, Tdap vaccination.” Id. at 5.
Respondent additionally concludes that Petitioner suffered the residual effects of his
condition for more than six months. Id. Respondent adds that, “based on the record as
it now stands and subject to his right to appeal the Findings of Fact, respondent does
not dispute that petitioner has satisfied all legal prerequisites for compensation under
the Act.” Id.
In view of Respondent’s position and the evidence of record, I find that
Petitioner is entitled to compensation.
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Additionally, Respondent clarifies that he is not waiving “any defenses that [he] may assert in the
damages phase.” Res. Report at 5 n.2.
2

================================================================================
DOCUMENT 3: USCOURTS-cofc-1_18-vv-01298-2
Date issued/filed: 2020-04-22
Pages: 5
Docket text: PUBLIC DECISION (Originally filed: 03/23/2020) regarding 36 DECISION Stipulation/Proffer Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01298-UNJ Document 40 Filed 04/22/20 Page 1 of 5
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 18-1298V
UNPUBLISHED
FRANKLIN GALLO, Chief Special Master Corcoran
Petitioner, Filed: March 23, 2020
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Damages Decision Based on Proffer;
HUMAN SERVICES, Tetanus Diphtheria acellular
Pertussis (Tdap) Vaccine; Shoulder
Respondent. Injury Related to Vaccine
Administration (SIRVA)
Leah VaSahnja Durant, Law Offices of Leah V. Durant, PLLC, Washington, DC, for
petitioner.
Julia Marter Collison, U.S. Department of Justice, Washington, DC, for respondent.
DECISION AWARDING DAMAGES1
On August 27, 2018, Franklin Gallo filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the
“Vaccine Act”). Petitioner alleges that he suffered a shoulder injury related to vaccine
administration (“SIRVA”) as a result of a tetanus, diphtheria, acellular pertussis (“Tdap”)
vaccine administered on September 5, 2017. Petition at 1. The case was assigned to
the Special Processing Unit of the Office of Special Masters.
On January 28, 2020, a ruling on entitlement was issued, finding Petitioner
entitled to compensation for his SIRVA. On March 19, 2020, Respondent filed a proffer
on award of compensation (“Proffer”) indicating Petitioner should be awarded
1 Because this unpublished decision contains a reasoned explanation for the action in this case, I am
required to post it on the United States Court of Federal Claims' website in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). This means the decision will be available to anyone with access
to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to
redact medical or other information, the disclosure of which would constitute an unwarranted invasion of
privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such
material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).

Case 1:18-vv-01298-UNJ Document 40 Filed 04/22/20 Page 2 of 5
$97,500.00. Proffer at 2. In the Proffer, Respondent represented that Petitioner agrees
with the proffered award. Id. at 1. Based on the record as a whole, I find that Petitioner
is entitled to an award as stated in the Proffer.
Pursuant to the terms stated in the attached Proffer, I award Petitioner a lump
sum payment of $97,500.00 in the form of a check payable to Petitioner. This
amount represents compensation for all damages that would be available under § 15(a).
The clerk of the court is directed to enter judgment in accordance with this
decision.3
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:18-vv-01298-UNJ Document 40 Filed 04/22/20 Page 3 of 5
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
FRANKLIN GALLO,
Petitioner, No. 18-1298V
Chief Special Master Corcoran
v. ECF
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
RESPONDENT’S PROFFER ON AWARD OF COMPENSATION
On August 27, 2018, Franklin Gallo (“petitioner”) filed a petition for compensation under
the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-1 to -34 (“Vaccine Act”
or “Act”), which alleged that petitioner received a tetanus, diphtheria and acellular pertussis
(“Tdap”) vaccination on September 5, 2017, and thereafter suffered a shoulder injury related to
vaccine administration (“SIRVA”), which is on the Vaccine Injury Table. On January 28, 2020,
the Chief Special Master issued a Ruling on Entitlement finding petitioner entitled to
compensation.
I. Items of Compensation
A. Pain and Suffering
Respondent proffers that petitioner should be awarded $97,500.00 in actual and projected
pain and suffering. This amount reflects that the award for projected pain and suffering has been
reduced to net present value. See 42 U.S.C. § 300aa-15(a)(4). Petitioner agrees.

Case 1:18-vv-01298-UNJ Document 40 Filed 04/22/20 Page 4 of 5
II. Form of the Award
Petitioner is a competent adult. Evidence of guardianship is not required in this case.
Respondent recommends that the compensation provided to petitioner should be made through a
lump sum payment as described below and requests that the Chief Special Master’s decision and
the Court’s judgment award the following1: a lump sum payment of $97,500.00, in the form of a
check payable to petitioner, Franklin Gallo.
III. Summary of Recommended Payments Following Judgment
Lump sum payable to petitioner, Franklin Gallo: $97,500.00
Respectfully submitted,
JOSEPH H. HUNT
Assistant Attorney General
C. SALVATORE D’ALESSIO
Acting Director
Torts Branch, Civil Division
CATHARINE E. REEVES
Deputy Director
Torts Branch, Civil Division
HEATHER L. PEARLMAN
Assistant Director
Torts Branch, Civil Division
1 Should petitioner die prior to entry of judgment, the parties reserve the right to move the
Court for appropriate relief. In particular, respondent would oppose any award for future lost
earnings and future pain and suffering.
2

Case 1:18-vv-01298-UNJ Document 40 Filed 04/22/20 Page 5 of 5
/s/ Julia M. Collison
JULIA M. COLLISON
Trial Attorney
Torts Branch, Civil Division
U.S. Department of Justice
P.O. Box 146
Ben Franklin Station
Washington, DC 20044-0146
Tel: (202) 305-0102
Dated: March 19, 2020
3